Harlé JR - Search Results

1

Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosus.

Morange PE, Alessi MC, Barthet MC, Aillaud MF, Harlé JR, Piquet P, Juhan-Vague I. Morange PE, et al. Among authors: harle jr. Thromb Haemost. 1997 Nov;78(5):1416-7. Thromb Haemost. 1997. PMID: 9408030 No abstract available.

2

Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.

Sanmarco M, Alessi MC, Harle JR, Sapin C, Aillaud MF, Gentile S, Juhan-Vague I, Weiller PJ. Sanmarco M, et al. Among authors: harle jr. Thromb Haemost. 2001 May;85(5):800-5. Thromb Haemost. 2001. PMID: 11372671

3

Lupus anticoagulants and antiphospholipid antibodies: comparison of clotting tests with an immunological assay.

Aillaud MF, Reviron D, Alessi MC, Harle JR, Amiral J, Juhan-Vague I. Aillaud MF, et al. Among authors: harle jr. Thromb Res. 1990 Oct 15;60(2):181-3. doi: 10.1016/0049-3848(90)90297-p. Thromb Res. 1990. PMID: 2126402 No abstract available.

4

Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.

Aillaud MF, Pignol F, Alessi MC, Harle JR, Escande M, Mongin M, Juhan-Vague I. Aillaud MF, et al. Among authors: harle jr. Thromb Haemost. 1986 Jun 30;55(3):330-2. Thromb Haemost. 1986. PMID: 3092390

5

Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus.

Karmochkine M, Berard M, Piette JC, Cacoub P, Aillaud MF, Harlé JR, Godeau P, Boffa MC, Harlet JR. Karmochkine M, et al. Among authors: harle jr. Lupus. 1993 Jun;2(3):157-60. doi: 10.1177/096120339300200305. Lupus. 1993. PMID: 8369806

6

[Thromboembolic risk remains uncertain in protein C deficiency].

Aillaud MF, Harle JR, Guidon C, Durand JM, Alessi MC, Juhan-Vague I, Weiller PJ, Mongin M. Aillaud MF, et al. Among authors: harle jr. Presse Med. 1985 Dec 7;14(42):2150. Presse Med. 1985. PMID: 2935804 French. No abstract available.

7

Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.

Berard M, Boffa MC, Karmochkine M, Aillaud MF, Juhan-Vague I, Francès C, Cacoub P, Piette JC, Harlé JR. Berard M, et al. Among authors: harle jr. J Lab Clin Med. 1993 Nov;122(5):601-5. J Lab Clin Med. 1993. PMID: 8228579

8

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC. Sanmarco M, et al. Among authors: harle jr. Thromb Haemost. 2007 Jun;97(6):949-54. Thromb Haemost. 2007. PMID: 17549297

9

Familial Mediterranean fever crisis and lupus anticoagulant.

Disdier P, Swiader L, Aillaud MF, Harlé JR, Weiller PJ. Disdier P, et al. Among authors: harle jr. Lancet. 1996 Nov 9;348(9037):1321-2. doi: 10.1016/s0140-6736(05)65811-4. Lancet. 1996. PMID: 8909414 No abstract available.

10

[Anetoderma during antiphospholipid syndrome. 3 cases].

Disdier P, Christides C, Andrac-Meyer L, Rojat-Habib MC, Aillaud MF, Swiader L, Weiller-Merli C, Berbis P, Harlé JR, Weiller PJ. Disdier P, et al. Among authors: harle jr. Ann Dermatol Venereol. 1996;123(12):800-3. Ann Dermatol Venereol. 1996. PMID: 9636765 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page